Invokana study shows Invokana patients twice as likely for risk of amputation
The Food and Drug Administration recently published a Drug Safety Commu...
The Food and Drug Administration recently issued a Drug Safety Communication adding warnings to the labels of sodium glucose-cotransporter (SGLT2) inh...
Invokana studies conducted at the University of San Diego this summer appear to show a link between taking the drug to treat type 1 diabetes and devel...
Janssen Pharmaceuticals paying doctors for speaking fees, consulting, and travel to promote Invokana
According to data provided by non-profit investi...
The Food and Drug Administration (FDA) recently bolstered warning labels for Invokana (canagliflozin) and Invokamet. The new prescription warning lab...
Therapeutic Goods Administration warns of ketoacidosis risk
This month, the Australian Department of Health’s Therapeutic Goods Administration (TGA) ...
American Association of Clinical Endocrinologists (AACE) to discuss links between drugs like Invokana and ketoacidosis
In October 2015, the American ...
FDA, ISMP warn Invokana users about possible risks of developing serious medical conditions
Invokana is part of a new class of type 2 diabetes medica...